Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.
Bauernfeind A, Grimm H, Schweighart S. Bauernfeind A, et al. Infection. 1990 Sep-Oct;18(5):294-8. doi: 10.1007/BF01647010. Infection. 1990. PMID: 2276823
Escherichia coli GRI was isolated from an ear exudate of a newborn. The strain was highly resistant to cefotaxime (MIC 128 mg/l). ...Thus, the enzyme produced by E. coli GRI represents a new plasmidic (plasmid pMVP-3) broad spectrum beta-lactamase (CTX-M) which may …
Escherichia coli GRI was isolated from an ear exudate of a newborn. The strain was highly resistant to cefotaxime (MIC 128 mg/l). ... …
Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan---Tunisian border region.
Bauernfeind A, Hohl P, Schneider I, Jungwirth R, Frei R. Bauernfeind A, et al. Clin Microbiol Infect. 1998 Mar;4(3):168-170. doi: 10.1111/j.1469-0691.1998.tb00384.x. Clin Microbiol Infect. 1998. PMID: 11864315 No abstract available.
Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
Ulrich E, Trautmann M, Krause B, Bauernfeind A, Hahn H. Ulrich E, et al. Among authors: bauernfeind a. Infection. 1989 Sep-Oct;17(5):311-5. doi: 10.1007/BF01650716. Infection. 1989. PMID: 2599653
The in vivo activity of ciprofloxacin against Pseudomonas aeruginosa was studied in a septicemia model in neutropenic mice and compared to that of other antibiotics with established activity against P. aeruginosa. When given as a single agent, ciprofloxacin proved t …
The in vivo activity of ciprofloxacin against Pseudomonas aeruginosa was studied in a septicemia model in neutropenic mice and compar …
Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.
Kempf P, Bauernfeind A, Müller A, Blum J. Kempf P, et al. Among authors: bauernfeind a. Infection. 1996 Nov-Dec;24(6):473-9. doi: 10.1007/BF01713053. Infection. 1996. PMID: 9007598 Clinical Trial.
Significantly more patients in the meropenem group had a satisfactory clinical response at the end of treatment (41/43 [95.3%] vs 30/40 [75.0%]; p = 0.008). ...Empirical meropenem monotherapy should prove a useful alternative to the currently standard combination tr …
Significantly more patients in the meropenem group had a satisfactory clinical response at the end of treatment (41/43 [95.3%] vs 30/ …
[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
Bauernfeind A, Petermüller C, Dietzel M. Bauernfeind A, et al. Infection. 1979;7(1):21-6. doi: 10.1007/BF01640552. Infection. 1979. PMID: 422252 German.
A comparison of carbenicillin, ticarcillin and azlocillin according to the concentrations at which half of the 233 strains were inhibited showed the ticarcillin values to be higher than those of azlocillin by a factor of 2.1, and carbenicillin values to be higher th
A comparison of carbenicillin, ticarcillin and azlocillin according to the concentrations at which half of the 233 strains were inhib
A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.
Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P, Röhnisch T, Schweighart S, Wilhelm R. Bauernfeind A, et al. Infection. 1992 May-Jun;20(3):158-63. doi: 10.1007/BF01704610. Infection. 1992. PMID: 1644493
The strains produced a plasmidic (pMVP-4) extended broad-spectrum beta-lactamase which is more active against cefotaxime than against ceftazidime (Vmax for cefotaxime 350 times higher than for ceftazidime). ...Thus, the beta-lactamase produced by S. typhimurium strains fro …
The strains produced a plasmidic (pMVP-4) extended broad-spectrum beta-lactamase which is more active against cefotaxime than against …
The influence of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime.
Bauernfeind A, Grimm H, Klietmann W, Opferkuch W, Werner H. Bauernfeind A, et al. Int J Antimicrob Agents. 1996 Apr;6 Suppl:S15-26. Int J Antimicrob Agents. 1996. PMID: 18611715
A total of 870 strains were investigated (481 Enterobacteriaceae, 57 Pseudomonas aeruginosa, 41 Acinetobacter spp., 194 Bacteroides fragilis and 97 Staphylococcus spp.). ...Thus the availability of SBT as a single-agent preparation for use in combination with variou
A total of 870 strains were investigated (481 Enterobacteriaceae, 57 Pseudomonas aeruginosa, 41 Acinetobacter spp., 194 Bacteroides f
Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?
Bauernfeind A, Chong Y, Lee K. Bauernfeind A, et al. Yonsei Med J. 1998 Dec;39(6):520-5. doi: 10.3349/ymj.1998.39.6.520. Yonsei Med J. 1998. PMID: 10097678 Review.
The major cluster includes several enzymes with a high similarity to CMY-2, which is the closest related chromosomal AmpC enzyme of Citrobacter freundii. A second cluster centers around CMY-1. It is less homogeneous and not closely related chromosomal AmpC enzymes. …
The major cluster includes several enzymes with a high similarity to CMY-2, which is the closest related chromosomal AmpC enzyme of C …
Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer.
Prodinger WM, Fille M, Bauernfeind A, Stemplinger I, Amann S, Pfausler B, Lass-Florl C, Dierich MP. Prodinger WM, et al. Among authors: bauernfeind a. J Clin Microbiol. 1996 Mar;34(3):564-8. doi: 10.1128/JCM.34.3.564-568.1996. J Clin Microbiol. 1996. PMID: 8904415 Free PMC article.
As confirmed by sequencing of a bla gene PCR fragment, all isolates expressed the SHV-5-type beta-lactamase. Genomic fingerprinting of epidemic strains with XbaI and pulsed-field gel electrophoresis grouped 20 of 21 isolates from ward A into two consecutive clusters …
As confirmed by sequencing of a bla gene PCR fragment, all isolates expressed the SHV-5-type beta-lactamase. Genomic fingerprinting o …
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.
Bauernfeind A, Wagner S, Jungwirth R, Schneider I, Meyer D. Bauernfeind A, et al. Antimicrob Agents Chemother. 1997 Sep;41(9):2041-6. doi: 10.1128/AAC.41.9.2041. Antimicrob Agents Chemother. 1997. PMID: 9303413 Free PMC article.
An Escherichia coli strain resistant to a broad spectrum of beta-lactams, including cephamycins, was isolated from a patient suffering from urinary tract infection. A resistance plasmid (pMVP-7) was transferred from the clinical isolate to an Escherichia coli …
An Escherichia coli strain resistant to a broad spectrum of beta-lactams, including cephamycins, was isolated from a patient s …
183 results
Jump to page
Feedback